The Scientist - Home

Researchers identified an enzyme that helps Plasmodium-infected red blood cells adhere to the placenta, providing molecular insights into placental malaria.

Scientists engineered T cells to protect instead of kill, potentially enabling targeted treatments for autoimmune disease and transplant rejection.

Sequencing bacterial genomes allows scientists to study bacterial diversity, immunity, and the human microbiome, but it requires targeted technologies.

A CRISPR-based system that erases itself from fly populations may offer a safer approach to tackling insecticide resistance while minimizing ecological risks.

Profiling cells from ovarian endometriosis revealed signaling interactions that may sustain lesion growth, highlighting potential therapeutic targets.

An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and possible regeneration.

Chemotherapy for breast cancer may be more effective during specific stages of the menstrual cycle, according to data from mice and humans.

Neurons that secrete the neuropeptide orexin help mice decide between exercise and snacking.

During translation, ribosomes can pause on the nucleic acid. Researchers showed that collisions from incoming proteins get them moving again.

Parasitic worms are difficult to kill with current therapies, but their commensal bacteria might be their Achilles’ heel.

New research uncovered an alarming accumulation of plastic particles in human brains, raising concerns about their potential role in neurodegenerative disease.

Neuroscientist and clinician Stephen Waxman explores new strategies to break the circuit of neuropathic pain.